BeOne Medicines is significantly bolstering its presence in the United States with a substantial $300 million investment earmarked for the…
Read More
Ipsen Acquires Rare Disease Specialist Memo Therapeutics for up to €700 Million, Bolstering Pipeline with Promising BK Polyomavirus Asset
Paris, France – In a significant strategic move to expand its rare disease portfolio, global biopharmaceutical company Ipsen announced today…
Read More
Absci Secures $100 Million and Advances AI-Designed Drug Candidate ABS-201 for Endometriosis and Hair Loss
Absci Corporation has successfully closed an underwritten public offering, raising approximately $100 million, a significant financial injection that will fuel…
Read More
The Enduring Secrets of Ancient Bone: New Study Reveals Preserved Collagen in 66-Million-Year-Old Dinosaur Fossil
For decades, the scientific consensus held that dinosaur fossils were essentially mineralized relics, their original organic components irrevocably lost to…
Read More
Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP
Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read More
Parabilis Medicines Aims for $475 Million Nasdaq IPO to Advance Lead Cancer Asset Zolucatetide
Parabilis Medicines, a promising biotechnology firm, is strategically positioning itself for a significant public market debut, announcing its intention to…
Read More
Parabilis Medicines Aims for $475 Million Nasdaq IPO to Fund Pivotal Desmoid Tumour Trial and Pipeline Expansion
Parabilis Medicines, a biopharmaceutical company forging innovative therapeutic pathways, is charting a course for public market debut with a proposed…
Read More
Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…
Read More
Evolution’s Ancient Blueprint: Researchers Uncover 120 Million-Year-Old Genetic "Cheat Sheet" Guiding Life’s Adaptations
Scientists have uncovered evidence that evolution has relied on the same genetic "cheat sheet" for more than 120 million years,…
Read More
Protuoso Biosciences Secures $9.5 Million Seed Funding to Pioneer Multifunctional Biologics for Complex Diseases
Protuoso Biosciences, a burgeoning US-based biotechnology company, has successfully closed a $9.5 million seed financing round, positioning itself to revolutionize…
Read MoreYOU MAY HAVE MISSED
